GSK’s Flonase Allergy Spray Gets Approval to Switch to an OTC Drug

GlaxoSmithKline said July 24 it received the go-ahead from the Food and Drug Administration to switch its Flonase allergy relief spray (fluticasone proprionate 50 mcg spray) from prescription to over-the-counter status.

Flonase Allergy Relief provides temporary relief of the symptoms of hay fever or upper respiratory allergies.

“With the significant number of allergy sufferers in the United States and a considerable number of those unsatisfied with their current treatments, we believe the wide availability of Flonase Allergy Relief over the counter is great news for these individuals,” Colin Mackenzie, president of Consumer Healthcare North America at GSK, said in a ...